CN Patent

CN110996910A — 抑郁障碍的治疗

Assigned to Ovid Therapeutics Inc · Expires 2020-04-10 · 6y expired

What this patent protects

提供了用于治疗抑郁障碍的制剂和使用加波沙朵或其药学上可接受的盐治疗抑郁障碍的方法。

USPTO Abstract

提供了用于治疗抑郁障碍的制剂和使用加波沙朵或其药学上可接受的盐治疗抑郁障碍的方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN110996910A
Jurisdiction
CN
Classification
—
Expires
2020-04-10
Drug substance claim
No
Drug product claim
No
Assignee
Ovid Therapeutics Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.